Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma

Cancer

Volumn 104, Issue 6, 2005, Pages 1113-1128

  Choi, Peter ^a,b   Chen, Chu ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gene ontology; Head and neck carcinoma; Microarray; Pathway; Ribosomal proteins

Indexed keywords

CELL ADHESION MOLECULE; RIBOSOME PROTEIN;

CELL DIFFERENTIATION; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MAPPING; GENOME ANALYSIS; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 24644449130     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21293     Document Type: Review

References (122)

1. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis [review]. Anticancer Res. 1998;18:4779-4786.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
3. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer [review]. J Natl Cancer Inst. 1993;85:95-111.
4. Genden EM, Ferlito A, Bradley PJ, Rinaldo A, Scully C. Neck disease and distant metastases. Oral Oncol. 2003;39:207-212.
5. Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag, 2002.
6. Hall SF, Groome PA, Rothwell D, Dixon PF. Using TNM staging to predict survival in patients with squamous cell carcinoma of head and neck. Head Neck. 1999;21:30-38.
7. Surveillance, Epidemiology, and End Results (SEER) program public-use data (1973-1998), National Cancer Institute, DC-CPS, Surveillance Reserach Program, Cancer Statistics Branch, released April 2001, based on the August 2000 submission.
8. Cooper JS, Berkey B, Marcial V, Fu KK, Lee DJ. Validation of the RTOG recursive partitioning classification for head and neck tumors. Head Neck. 2001;23:669-677.
9. Lydiatt WM, Shah JP, Hoffman HT. Head and Neck Sites Task Force. American Joint Committee on Cancer. AJCC stage groupings for head and neck cancer: should we look at alternatives? A report of the Head and Neck Sites Task Force. Head Neck. 2001;23:607-612.
10. Hall SF, Groome PA, Dixon PF. Does TANIS (T And N Integer Score) help predict survival? J Otolaryngol. 1997;26:8-12.
11. Baatenburg de Jong RJ, Hermans J, Molenaar J, Briaire JJ, le Cessie S. Prediction of survival in patients with head and neck cancer. Head Neck. 2001;23:718-724.
12. Pugliano FA, Piccirillo JF, Zequeira MR, et al. Clinical-severity staging system for oropharyngeal cancer: five-year survival rates. Arch Otolaryngol Head Neck Surg. 1997;123: 1118-1124.
13. Howaldt HP, Kainz M, Euler B, Vorast H. Proposal for modification of the TNM staging classification for cancer of the oral cavity. DOSAK. J Craniomaxillofac Surg. 1999;27:275-288.
14. Lacy PD, Spitznagel EL Jr., Piccirillo JF. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma. Cancer. 1999;86:1387-1395.
15. Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Cassisi NJ. Stratification of stage IV SCC of the oropharynx. Head Neck. 2000;22:626-628.
16. Groome PA, Schulze KM, Mackillop WJ, et al. A comparison of published head and neck stage groupings in carcinomas of the tonsillar region. Cancer. 2001;92:1484-1494.
17. Groome PA, Schulze K, Boysen M, Hall SF, Mackillop WJ. A comparison of published head and neck stage groupings in carcinomas of the oral cavity. Head Neck. 2001;23:613-624.
18. Groome PA, Schulze K, Boysen M, et al. A comparison of published head and neck stage groupings in laryngeal cancer using data from two countries. J Clin Epidemiol. 2002; 55:533-544.
19. Sudbo J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med. 2001;344:1270-1278.
20. Sudbo J, Ried T, Bryne M, Kildal W, Danielsen H, Reith A. Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. Oral Oncol. 2001; 37:558-565.
21. Hittelman WN, Voravud N, Shin DM, Lee JS, Ro JY, Hong WK. Early genetic changes during upper aerodigestive tract tumorigenesis [review]. J Cell Biochem- Suppl. 1993;17F:233-236.
22. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972;29:1446-1449.
23. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990;66:109-113.
24. Candela FC, Kothari K, Shah JP. Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck. 1990;12:197-203.
25. Baker SR. Malignant neoplasms of the oral cavity. In: Cummings CW, Fredrickson JM, Krause CJ, Richardson MA, Schuller DE, editors. Otolaryngology-head and neck surgery. 2nd ed. St. Louis: Mosby, 1993:1248-1305.
26. Eisele DW, Johns ME. Carcinoma of the oral cavity and pharynx. In: Lee KJ, editor. Essential otolaryngology-head and neck surgery. 5th ed. New York: Elsevier Science Publishing Company, Inc., 1991:493-512.
27. Thawley SE, O'Leary MO. Malignant neoplasms of the oropharynx. In: Cummings CW, Fredrickson JM, Krause CJ, Richardson MA, Schuller DE, editors. Otolaryngology-head and neck surgery. 2nd ed. St. Louis: Mosby, 1993:1310-1311.
28. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck [see comments]. N Engl J Med. 1995;332: 429-435.
29. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56:2488-2492.
30. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953;6:963-968.
31. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res. 1996;56:2484-2487.
32. Chin D, Boyle GM, Theile DR, Parsons PG, Coman WB. Molecular introduction to head and neck cancer (HNSCC) carcinogenesis [review]. Br J Plastic Surg. 2004;57:595-602.
33. Kim MM, Califano JA. Molecular pathology of head and neck cancer. Int J Cancer. 2004;112:545-553.
34. Ishwad CS, Ferrell RE, Rossie KN, et al. Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer. Int J Cancer. 1996;69:1-4.
35. Roz L, Wu CL, Porter S, et al. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res. 1996;56:1228-1231.
36. Bockmuhl U, Schwendel A, Dietel M, Petersen I. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res. 1996; 56:5325-5329.
37. Callender T, El Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer. 1994;74:152-158.
38. Meredith SD, Levine PA, Burns JA, et al. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma-association with poor prognosis. Arch Otolaryngol- Head Neck Surg. 1995;121:790-794.
39. Bockmuhl U, Kuchler I, Petersen I. Improved prognostic assessment of head-neck carcinomas by new genetic markers [English translation of German text]. HNO. 2000;48:451-456.
40. Namazie A, Alavi S, Olopade OI, et al. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope. 2002;112: 472-481.
41. Jares P, Fernandez PL, Campo E, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994;54:4813-4817.
42. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA. 1994;91: 9871-9875.
43. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene [see comments] [review]. N Engl J Med. 1993;329:1318-1327.
44. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the P53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332:712-717.
45. Ahomadegbe JC, Barrois M, Fogel S, et al. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene. 1995;10:1217-1227.
46. Melhem MF, Law JC, el Ashmawy L, et al. Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers. Am J Pathol. 1995;146:1170-1177.
47. El Naggar AK, Lai S, Luna MA, et al. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer. 1995;64:196-201.
48. Nylander K, Schildt EB, Eriksson M, Magnusson A, Mehle C, Roos G. A non-random deletion in the p53 gene in oral squamous cell carcinoma. Br J Cancer. 1996;73:1381-1386.
49. Nylander K, Nilsson P, Mehle C, Roos G. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. Br J Cancer. 1995;71:826-830.
50. Ogden GR, Chisholm DM, Morris AM, Stevenson JH. Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease. J Pathol. 1997;182:180-184.
51. Rich AM, Kerdpon D, Reade PC. p53 expression in oral precancer and cancer. Aust Dental J. 1999;44:103-105.
52. Yarbrough WG, Shores C, Witsell DL, Weissler MC, Fidler ME, Gilmer TM. ras mutations and expression in head and neck squamous cell carcinomas. Laryngoscope. 1994;104: 1337-1347.
53. McDonald JS, Jones H, Pavelic ZP, Pavelic LJ, Stambrook PJ, Gluckman JL. Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck. J Oral Pathol Med. 1994;23:342-346.
54. Irish JC, Bernstein A. Oncogenes in head and neck cancer. Laryngoscope. 1993;103:42-52.
55. Xia W, Lau YK, Zhang HZ, et al. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res. 1997; 3:3-9.
56. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray [see comments]. Science. 1995;270: 467-470.
57. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays [review]. Nature Genet. 1999; 21:33-37.
58. Whipple ME, Kuo WP. DNA microarrays in otolaryngology-head and neck surgery [review]. Otolaryngol- Head Neck Surg. 2002;127:196-204.
59. Warner GC, Reis PP, Makitie AA, et al. Current applications of microarrays in head and neck cancer research [review]. Laryngoscope. 2004;114:241-248.
60. Sotiriou C, Lothaire P, Dequanter D, Cardoso F, Awada A. Molecular profiling of head and neck tumors [review]. Curr Opin Oncol. 2004;16:211-214.
61. Huang J, Qi R, Quackenbush J, Dauway E, Lazaridis E, Yeatman T. Effects of ischemia on gene expression. J Surg Res. 2001;99:222-227.
62. Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR, Liotta LA. Laser-capture microdissection: opening the microscopic frontier to molecular analysis [review]. Trends Genet. 1998;14:272-276.
63. Mueller MM, Fusenig NE. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells [review]. Differentiation. 2002;70:486-497.
64. Matrisian LM, Cunha GR, Mohla S. Epithelial-stromal interactions and tumor progression: meeting summary and future directions. Cancer Res. 2001;61:3844-3846.
65. Shekhar MPV, Werdell J, Santner SJ, Pauley RJ, Tait L. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res. 2001;61:1320-1326.
66. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res. 2000; 60:2562-2566.
67. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells [see comment]. N Engl J Med. 2004;351:2159-2169.
68. Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol. 2005;173:10-20.
69. Tumor Analysis Best Practices Working Group. Expression profiling-best practices for data generation and interpretation in clinical trials. Nature Rev Genet. 2004;5:229-237.
70. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 1919; 2003;19:185-193.
71. Ambroise C, McLachlan GJ. Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci USA. 2002;99:6562-6566.
72. Leung YF, Cavalieri D. Fundamentals of cDNA microarray data analysis [review]. Trends Genet. 2003;19:649-659.
73. Alevizos I, Mahadevappa M, Zhang X, et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene. 2001;20: 6196-6204.
74. Al Moustafa AE, Alaoui-Jamali MA, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene. 2002;21:2634-2640.
75. Belbin TJ, Singh B, Barber I, et al. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res. 2002;62:1184-1190.
76. Belbin TJ, Singh B, Smith RV, et al. Molecular profiling of tumor progression in head and neck cancer. Arch Otolaryngol- Head Neck Surg. 2005;131:10-18.
77. Chin D, Boyle GM, Williams RM, et al. Novel markers for poor prognosis in head and neck cancer. Int J Cancer. 2005; 113:789-797.
78. Chung CH, Parker JS, Karaca G, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 2004;5:489-500.
79. Cromer A, Carles A, Millon R, et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene. 2004;23:2484-2498.
80. El Naggar AK, Kim HW, Clayman GL, et al. Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification. Oncogene. 2002;21:8206-8219.
81. Ginos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 2004;64:55-63.
82. Gonzalez HE, Gujrati M, Frederick M, et al. Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol- Head Neck Surg. 2003;129: 754-759.
83. Ha PK, Benoit NE, Yochem R, et al. A transcriptional progression model for head and neck cancer. Clin Cancer Res. 2003;9:3058-3064.
84. Hwang D, Alevizos I, Schmitt WA, et al. Genomic dissection for characterization of cancerous oral epithelium tissues using transcription profiling. Oral Oncol 2003;39:259-268.
85. Irie T, Aida T, Tachikawa T. Gene expression profiling of oral squamous cell carcinoma using laser microdissection and cDNA microarray. Med Electron Microsc. 2004;37:89-96.
86. Jeon GA, Lee JS, Patel V, et al. Global gene expression profiles of human head and neck squamous carcinoma cell lines. Int J Cancer. 2004;112:249-258.
87. Kuriakose MA, Chen WT, He ZM, et al. Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci. 2004;61:1372-1383.
88. Leethanakul C, Patel V, Gillespie J, et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene. 2000;19:3220-3224.
89. Leethanakul C, Knezevic V, Patel V, et al. Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol. 2003;39:248-258.
90. Mendez E, Cheng C, Farwell DG, et al. Transcriptional expression profiles of oral squamous cell carcinomas. Cancer. 2002;95:1482-1494.
91. Moriya T, Seki N, Shimada K, et al. In-house cDNA microarray analysis of gene expression profiles involved in SCC cell lines. Int J Mol Med. 2003;12:429-435.
92. Nagata M, Fujita H, Ida H, et al. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer. 2003; 106:683-689.
93. O'Donnell RK, Kupferman M, Wei SJ, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene. 2005;24:1244-1251.
94. Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nature Genet. 2005;37:182-186.
95. Schmalbach CE, Chepeha DB, Giordano TJ, et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:295-302.
96. Sok JC, Kuriakose MA, Mahajan VB, Pearlman AN, DeLacure MD, Chen FA. Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg. 2003;129:760-770.
97. Squire JA, Bayani J, Luk C, et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: by comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck. 2002;24:874-887.
98. Villaret DB, Wang T, Dillon D, et al. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope. 2000;110:374-381.
99. Warner GC, Reis PP, Jurisica I, et al. Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer. 2004; 110:857-868.
100. Sultan M, Wigle DA, Cumbaa CA, et al. Binary tree-structured vector quantization approach to clustering and visualizing microarray data. Bioinformatics. 2002;18:S111-S119.
101. Zhang Y, Lu H, Dazin P, Kapila Y. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. J Biol Chem. 2004; 279:48342-48349.
102. Shintani S, Ishikawa T, Nonaka T, et al. Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer. Oncology. 2004;66:316-322.
103. Ziober BL, Turner MA, Palefsky JM, Banda MJ, Kramer RH. Type I collagen degradation by invasive oral squamous cell carcinoma. Oral Oncol. 2000;36:365-372.
104. Wang YF, Chang SY, Tai SK, Li WY, Wang LS. Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck. 2002;24: 850-858.
105. Macabeo-Ong M, Shiboski CH, Silverman S, et al. Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression. Oral Oncol. 2003;39:638-647.
106. St John MA, Li Y, Zhou X, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:929-935.
107. Dang D, Yang Y, Li X, et al. Matrix metalloproteinases and TGFbeta1 modulate oral tumor cell matrix. Biochem Biophys Res Commun. 2004;316:937-942.
108. Koivisto L, Grenman R, Heino J, Larjava H. Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin. Exp Cell Res. 2000;255:10-17.
109. Ramos DM, Chen B, Regezi J, Zardi L, Pytela R. Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer. 1998;75:680-687.
110. Pauli C, Stieber P, Schmitt UM, Andratschke M, Hoffmann K, Wollenberg B. The significance of tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck. Anticancer Res. 2002;22:3093-3097.
111. Jordan RC, Macabeo-Ong M, Shiboski CH, et al. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res. 2004;10:6460-6465.
112. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nature Genet. 2002; 31:19-20.
113. Schliephake H. Prognostic relevance of molecular markers of oral cancer - a review. Int J Oral Maxillofac Surg. 2003; 32:233-245.
114. Werner JA, Rathcke IO, Mandic R. The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck [review]. Clin Exp Metastasis. 2002;19:275-282.
115. Mignogna MD, Fedele S, Lo RL, Lo ML, Bucci E. Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? [review]. Oral Oncol. 2004;40:120-130.
116. Kasai H, Nadano D, Hidaka E, et al. Differential expression of ribosomal proteins in human normal and neoplastic colorectum. J Histochem Cytochem. 2003;51:567-574.
117. Sengpiel V, Rost T, Gorogh T, Rathcke IO, Werner JA. S19-mRNA expression in squamous cell carcinomas of the upper aerodigestive tract. Anticancer Res. 2004;24:2161-2167.
118. Amsterdam A, Sadler KC, Lai K, et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2004;2: E139.
119. Jacks T. Tumor suppressor gene mutations in mice [review]. Annu Rev Genet. 1996;30:603-636.
120. Goldstein JL, Brown MS. Regulation of the mevalonate pathway [review]. Nature. 1990;343:425-430.
121. Zhu K, Hamilton AD, Sebti SM. Farnesyltransferase inhibitors as anticancer agents: current status [review]. Curr Opin Invest Drugs. 2003;4:1428-1435.
122. Dimitroulakos J, Marhin WH, Tokunaga J, et al. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas. Neoplasia (New York). 2002;4:337-346.